Answers are grounded in this paper and cite their sources.
The nigrostriatal system is especially vulnerable to neurodegeneration in Parkinson's disease (PD) and the blood-brain barrier (BBB) is a limiting factor for delivery of therapeutic agents to the brain. This pilot study aimed to demonstrate safety, feasibility and tissue penetration (by 18F-Choline-positron emission tomography (PET)) of MR-guided focused ultrasound (MRgFUS) simultaneous BBB opening (BBB-O) in the substantia nigra (SN) and putamen in PD.
No takes yet. Share an insight, caveat, or question.
Gasca‐Salas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: